China’s elite switch preference to Paxlovid from liquor brand Moutai as demand soars for COVID drug

Share this & earn $10
Published at : January 05, 2023
Subscribe
Pfizer’s antiviral is ‘more coveted than Moutai’ as authorities restrict imports despite the virus wave, reported Financial Times on December 28.
-------------------
#SpotlightOnChina #China #ChinaInsights China’s elite switch preference to Paxlovid from liquor brand Moutai as demand soars for COVID drug
Spotlight on ChinaChina InsightsChina News